SYNTHETIC ROYALTY AGREEMENTSynthetic Royalty Agreement • March 7th, 2022 • Acer Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 7th, 2022 Company Industry JurisdictionThis SYNTHETIC ROYALTY AGREEMENT (this “Agreement”) dated as of March 4, 2022, is among Acer Therapeutics Inc., a Delaware corporation (the “Company”), MAM Aardvark, LLC, a Delaware limited liability company (as “Agent”), and Marathon Healthcare Finance Fund, L.P., a Delaware limited partnership (“MHFF”).